Published in Clin Infect Dis on September 01, 1997
Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol (2000) 3.03
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am J Respir Crit Care Med (2009) 2.80
A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol (2006) 1.86
Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection (2007) 1.79
Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun (2001) 1.74
Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test. J Clin Microbiol (1999) 1.67
T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect Immun (1999) 1.38
Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One (2010) 1.34
Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design. Infect Immun (2004) 1.21
Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response. PLoS One (2007) 1.10
Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol (2007) 1.09
Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev (2011) 1.01
Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time. PLoS One (2008) 0.98
Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria. J Clin Immunol (2000) 0.95
Modulation of cell death by M. tuberculosis as a strategy for pathogen survival. Clin Dev Immunol (2011) 0.92
Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis. Tuberculosis (Edinb) (2008) 0.92
Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area. BMC Infect Dis (2009) 0.89
Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis. Infect Immun (2001) 0.88
IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis. Autophagy (2014) 0.83
CD11c(+) CD103(+) cells of Mycobacterium tuberculosis-infected C57BL/6 but not of BALB/c mice induce a high frequency of interferon-γ- or interleukin-17-producing CD4(+) cells. Immunology (2015) 0.83
Factors that Predict Negative Results of QuantiFERON-TB Gold In-Tube Test in Patients with Culture-Confirmed Tuberculosis: A Multicenter Retrospective Cohort Study. PLoS One (2015) 0.82
Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis (2011) 0.82
CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens. Clin Diagn Lab Immunol (2005) 0.82
Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to Mycobacterium tuberculosis. J Infect Dis (2012) 0.81
Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. Mediators Inflamm (2003) 0.81
Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis. Respiration (2010) 0.79
Performance of whole-blood interferon-gamma release assay in patients admitted to the emergency department with pulmonary infiltrates. BMC Infect Dis (2011) 0.78
Diagnostic values of the QuantiFERON-TB Gold In-tube assay carried out in China for diagnosing pulmonary tuberculosis. PLoS One (2015) 0.78
Lymphoproliferative responses to mitogens and prepared antigens of M. avium complex in patients with HIV infection. J Clin Immunol (2000) 0.78
Impaired gamma interferon response to Mycobacterium vaccae antigens in patients with cavitary pulmonary tuberculosis. Clin Vaccine Immunol (2008) 0.77
Diagnostic Utility of QuantiFERON-TB Gold (QFT-G) in Active Pulmonary Tuberculosis. J Glob Infect Dis (2015) 0.77
Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients. Adv Biomed Res (2017) 0.75
Evaluation of immunological parameters in purified protein derivative positive tuberculin workers. Iran J Basic Med Sci (2013) 0.75
Comparison of the genomes of two Xanthomonas pathogens with differing host specificities. Nature (2002) 8.42
A topological Dirac insulator in a quantum spin Hall phase. Nature (2008) 7.44
A tunable topological insulator in the spin helical Dirac transport regime. Nature (2009) 4.98
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax (2008) 4.79
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res (1993) 4.11
Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis (1993) 4.01
Observation of unconventional quantum spin textures in topological insulators. Science (2009) 3.58
Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1999) 3.45
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci (2000) 2.55
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51
Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol (1998) 2.49
Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med (1990) 2.35
Phylogenetic analysis of rumen bacteria by comparative sequence analysis of cloned 16S rRNA genes. Anaerobe (1998) 2.31
Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis (1999) 2.29
Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol (1998) 2.29
Observation of time-reversal-protected single-dirac-cone topological-insulator states in Bi2Te3 and Sb2Te3. Phys Rev Lett (2009) 2.22
Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol (2001) 2.16
The first clinical and epidemiological programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial Transplant (1998) 2.16
Endoscopic diagnosis and treatment of an esophageal bezoar resulting from bulk laxative ingestion. Endoscopy (1994) 2.14
Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol (1994) 2.06
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) (2011) 2.00
Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98
The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res (1993) 1.88
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85
Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res (2001) 1.78
Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med (1997) 1.76
Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74
Testing an intervention to prevent further abuse to pregnant women. Res Nurs Health (1999) 1.67
IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65
Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia (2011) 1.63
Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. J Gastroenterol (2001) 1.62
Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol (1998) 1.59
Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun (1998) 1.58
An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer. Rev Port Pneumol (2008) 1.53
Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med (2001) 1.53
Evaluation of method for secondary DNA typing of Mycobacterium tuberculosis with pTBN12 in epidemiologic study of tuberculosis. J Clin Microbiol (1996) 1.52
Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51
Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia (1993) 1.50
The role of white cells in the transmission of Yersinia enterocolitica in blood components. Transfusion (1992) 1.48
Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry (1994) 1.45
Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med (1996) 1.43
[Characterization of a Portuguese population with systemic lupus erytematosus]. Acta Reumatol Port (2007) 1.42
Undiagnosed tuberculosis in patients with human immunodeficiency virus infection. Chest (1990) 1.41
Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene (2007) 1.40
Rapid diagnostic tests for tuberculosis: progress but no gold standard. Am J Respir Crit Care Med (1997) 1.40
Cytometry of cyclin proteins. Cytometry (1996) 1.40
Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia (2009) 1.37
Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem (1997) 1.36
Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med (Berl) (2009) 1.33
Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc Natl Acad Sci U S A (1994) 1.33
CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis (1997) 1.32
Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus. Horm Metab Res (2007) 1.31
A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J (1998) 1.31
Observation of a topological crystalline insulator phase and topological phase transition in Pb(1-x)Sn(x)Te. Nat Commun (2012) 1.30
Elevated blood pressure in subjects with lipodystrophy. AIDS (2001) 1.30
Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene (2007) 1.30
Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol (1997) 1.30
CD30 in normal and neoplastic cells. Clin Immunol (1999) 1.29
Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun (1998) 1.29
Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond) (2009) 1.28
Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine (1999) 1.27
Fermi surface topology and low-lying quasiparticle dynamics of parent Fe1+xTe/Se superconductor. Phys Rev Lett (2009) 1.25
Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev (1999) 1.23
Severity of abuse to pregnant women and associated gun access of the perpetrator. Public Health Nurs (1998) 1.23
Safety behaviors of abused women after an intervention during pregnancy. J Obstet Gynecol Neonatal Nurs (1998) 1.20
Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria. J Appl Microbiol (2006) 1.19
IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils. J Leukoc Biol (2001) 1.18
Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med (1989) 1.15
Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis (2001) 1.15
DNA strand breaks occurring during apoptosis - their early insitu detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol (1992) 1.15
Hazard of smoking initiation by age among adolescents in Wuhan, China. Prev Med (2001) 1.15
Mitochondrial genotype associated with longevity and its inhibitory effect on mutagenesis. Mech Ageing Dev (2000) 1.14
Rapid and sensitive detection of Singapore grouper iridovirus by loop-mediated isothermal amplification. J Appl Microbiol (2008) 1.13
Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas. J Clin Microbiol (1999) 1.13
Resource use by abused women following an intervention program: associated severity of abuse and reports of abuse ending. Public Health Nurs (1997) 1.12
Structure, function and regulation of p63 and p73. Cell Death Differ (1999) 1.12
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours. Br J Cancer (2011) 1.12
T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun (2001) 1.11
Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients. J Acquir Immune Defic Syndr (2001) 1.11
The T cell receptors of human gamma delta T cells reactive to Mycobacterium tuberculosis are encoded by specific V genes but diverse V-J junctions. J Immunol (1991) 1.11
Effects of spectral smearing on phoneme and word recognition. J Acoust Soc Am (1996) 1.10
Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis (2000) 1.10
Evidence for a superantigen in human tuberculosis. Immunity (1994) 1.10
Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun (2000) 1.08
Antimycobacterial antibody levels in pleural fluid as reflection of passive diffusion from serum. Chest (1990) 1.07